CARDIOVASCULAR JOURNAL OF AFRICA • Volume 34, No 5, November/December 2023 AFRICA 317 35. Bakare OQ, Akinyinka MR, Goodman O, Kuyinu YA, Wright OK, Adeniran A, et al. Antihypertensive use, prescription patterns, and cost of medications in a Teaching Hospital in Lagos, Nigeria. Niger J Clin Pract 2016; 19(5): 668–672. 36. Busser D, Yarlagadda R, Ahmed SM. Assessment of antihypertensive drugs utilization pattern in Butajira zonal hospital, Butajira town, south Ethiopia. Int J Pharm Sci Res 2016; 7(10): 4028–4034. 37. Kika TM, Lepira FB, Kayembe PK, Makulo JR, Sumaili EK, Kintoki EV, et al. Uncontrolled hypertension among patients managed in primary healthcare facilities in Kinshasa, Democratic Republic of the Congo. Cardiovasc J Afr 2016; 27(6): 361–366. 38. Ssinabulya I, Nabunnya Y, Kiggundu B, Musoke C, Mungoma M, Kayima J. Hypertension control and care at Mulago Hospital ambulatory clinic, Kampala-Uganda. BMC Res Notes 2016; 9(1): 487. 39. Adejumo O, Okaka E, Iyawe I. Prescription pattern of antihypertensive medications and blood pressure control among hypertensive outpatients at the University of Benin Teaching Hospital in Benin City, Nigeria. Malawi Med J 2017; 29(2): 113. 40. Berhe DF, Taxis K, Haaijer-Ruskamp FM, Mulugeta A, Mengistu YT, Mol PGM. Hypertension treatment practices and its determinants among ambulatory patients: retrospective cohort study in Ethiopia. Br Med J Open 2017; 7(8): e015743. 41. Mbui JM, Oluka MN, Guantai EM, Sinei KA, Achieng L, Baker A, et al. Prescription patterns and adequacy of blood pressure control among adult hypertensive patients in Kenya; findings and implications. Expert Rev Clin Pharmacol 2017; 10(11): 1263–1271. 42. Olowofela AO, Isah AO. A profile of adverse effects of antihypertensive medicines in a tertiary care clinic in Nigeria. Ann Afr Med 2017; 16(3): 114–119. 43. Teshome DF, Demssie AF, Zeleke BM. Determinants of blood pressure control amongst hypertensive patients in Northwest Ethiopia. Shimosawa T (ed). PloS One 2018; 13(5): e0196535. 44. Furberg CD, Psaty BM. JNC VI guidelines. Lancet 1998; 351(9098): 289–290. 45. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42(6): 1206–1252. 46. Abel N, Contino K, Jain N, Grewal N, Grand E, Hagans I, et al. Eighth Joint National Committee (JNC-8) guidelines and the outpatient management of hypertension in the African-American population. North Am J Med Sci 2015; 7(10): 438–445. 47. Mansia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 ESH-ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Blood Press 2007; 16(3): 135–232. 48. Mancia G, Fagard R, Narkiewicz K, Redo´n J, Zanchetti A, Bo¨hm M, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013; 31: 1281–1357. 49. Mabadeje AF. WHO-ISH guidelines for the management of hypertension: implementation in Africa – the Nigerian experience. Clin Exp Hypertens 1999; 21(5–6): 671–681. 50. Adeloye D, Basquill C. Estimating the prevalence and awareness rates of hypertension in Africa: a systematic analysis. PloS One 2014; 9(8): e104300. 51. Kayima J, Wanyenze RK, Katamba A, Leontsini E, Nuwaha F. Hypertension awareness, treatment and control in Africa: A systematic review. BMC Cardiovasc Disord 2 Aug 2013. 52. Deborde T, Amar L, Bobrie G, Postel-Vinay N, Battaglia C, Tache A, et al. Sex differences in antihypertensive treatment in France among 17 856 patients in a tertiary hypertension unit. J Hypertens 2018; 36(4): 939–946. 53. Macquart De Terline D, Antignac M, Diop IB, Kramoh KE, Kingue S, Houenassi DM, et al. Evaluation of adherence to cardiovascular treatment among hypertensive patients in Africa: EIGHT study. Eur Heart J 2016; 37: 1231. 54. Rea F, Corrao G, Merlino L, Mancia G. Initial Antihypertensive treatment strategies and therapeutic inertia. Hypertension 2018; 72(4): 846–853. 55. Mente A, O’Donnell MJ, Rangarajan S, McQueen MJ, Poirier P, Wielgosz A, et al. Association of urinary sodium and potassium excretion with blood pressure. N Engl J Med 2014; 371(7): 601–611. 56. Attaei MW, Khatib R, McKee M, Lear S, Dagenais G, Igumbor EU, et al. Availability and affordability of blood pressure-lowering medicines and the effect on blood pressure control in high-income, middle-income, and low-income countries: an analysis of the PURE study data. Lancet Public Health 2017; 2(9): e411–419. 57. Ojji DB, Mayosi B, Francis V, Badri M, Cornelius V, Smythe W, et al. Comparison of Dual Therapies for Lowering Blood Pressure in Black Africans. N Engl J Med 2019; 380(25): 2429–2439. 58. Rockers PC, Laing RO, Ashigbie PG, Onyango MA, Mukiira CK, Wirtz VJ. Effect of Novartis Access on availability and price of non-communicable disease medicines in Kenya: a cluster-randomised controlled trial. Lancet Glob Health 2019; 7(4): e492–502. 59. Geldsetzer P, Manne-Goehler J, Marcus M-E, Ebert C, Zhumadilov Z, Wesseh CS, et al. The state of hypertension care in 44 low-income and middle-income countries: a cross-sectional study of nationally representative individual-level data from 1.1 million adults. Lancet 2019; 394(10199): 652–662. 60. Mbaye R, Gebeyehu R, Hossmann S, Mbarga N, Bih-Neh E, Eteki L, et al. Who is telling the story? A systematic review of authorship for infectious disease research conducted in Africa, 1980–2016. BMJ Glob Health 2019; 4(5): e001855. 61. Roth GA, Nguyen G, Forouzanfar MH, Mokdad AH, Naghavi M, Murray CJL. Estimates of global and regional premature cardiovascular mortality in 2025. Circulation 2015 Sep 29; 132(13): 1270–1282. 62. Chow CK, Teo KK, Rangarajan S, Islam S, Gupta R, Avezum A, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. J Am Med Assoc 2013; 310(9): 959–968.
RkJQdWJsaXNoZXIy NDIzNzc=